USPTO serial 79368859
ONCOBODIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 7, 2024
- Examiner
- VAGHANI, MAYUR C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ONCOBODIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roberta S. Bren
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.125 S. Royal St.Alexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals; carrier excipients for use in the manufacture of pharmaceutical preparations | ACTIVE | — |
| 005 | Drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biochemical medicines for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of cancer | ACTIVE | — |
| 042 | Pharmaceutical research services; scientific research in the nature of conducting clinical trials for pharmaceuticals for others; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology | ACTIVE | — |
| 044 | In vitro analysis for medical and pharmaceutical use, namely, analysis for medical diagnostic or treatment purposes; in vitro testing for medical and pharmaceutical use, namely, testing for medical diagnostic or treatment purposes; consultancy and information services provided via the Internet relating to pharmaceutical products, namely pharmaceutical consultation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LinXis B.V.
- Other trademarks owned by LinXis B.V.
- Other trademarks owned by LinXis B.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ONCOBODIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 14, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 23, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 4, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 4, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 20, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 7, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 7, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 7, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 7, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 1, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 7, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 7, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 5, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |